ZOM Stock

Is Zomedica (ZOM) Stock Worth Buying After Reported Its Results For The First Quarter?

Zomedica (NYSEAMERICAN: ZOM) stock fell by 4% since the company released its results for the first quarter of 2021 on May 12. The company's revenue for the quarter was $14,124. Zomedica explained that it commenced its commercialization of TRUFORMA on March 15, 2021, and accordingly had only limited sales activity in the first quarter of 2021.
www.investreader.com - May 15, 2021

Why ZOM, NAKD, AMC, OCGN And Other Reddit Stocks Soared Monday?

Very large retail buyers on Reddit and other social media sites are taking concerted action to drive up the price of these stocks.
www.investreader.com - April 27, 2021

Will Zomedica (ZOM) Stock Rise After Announcing Plans To Build Direct Sales Force For Truforma?

Zomedica intended to transition from a distributor-based sales model to a direct sales organization.
www.investreader.com - April 20, 2021

ZOM Stock: When To Buy Zomedica Stock?

All things seem to be in the next earnings report of the company.
www.investreader.com - April 14, 2021

ZOM Stock: Is It Time To Buy Zomedica Stock?

Some investors looking to lower the price of this stock and realize the purpose of price correction.
www.investreader.com - April 06, 2021

What's Wrong With Zomedica (ZOM) Stock?

Although Zomedica reported the first commercial sale of its Truforma, this good news did not drive its stock price up.
www.investreader.com - March 28, 2021

Zomedica's Pet Lab Product Launch Will Push Its Value Higher

Zomedica’s pet lab product launch will push its value higher. ZOM stock is worth between $2.45 to $3.17 with 10% market share.
investorplace.com - March 23, 2021

Zomedica is a Bet Worth Taking That Makes Sense

ZOM stock is simply too good of an opportunity to pass by. Veterinary diagnostics is a growing sector, and ZOM revenues are just beginning.
investorplace.com - March 22, 2021

Zomedica’s Early Launch Is Music to Shareholders’ Ears

Zomedica launched its Truforma point-of-care diagnostic platform March 16, ahead of schedule. That’s excellent news if you own ZOM stock.
investorplace.com - March 22, 2021

ZOM Stock: Why Zomedica Stock Fell After Its First Commercial Sale for Truforma?

Investors are quickly figuring out that the current $2 billion market cap is a high valuation for Zomedica.
www.investreader.com - March 21, 2021

ZOM Stock Soars After Commercial Launch, but It's Not Sustainable

Investors in ZOM stock have been well-rewarded of late, as the company announced its first commercial sale of its flagship product.
investorplace.com - March 20, 2021

Zomedica Is Not For the Weak-Handed Investor

Zomedica is launching a product that will bring should bring revenue. But with a small addressable market, ZOM stock may have little upside.
investorplace.com - March 19, 2021

Zomedica Is Caught in a Tantalizing Trading Setup

ZOM stock slipped since the last time I covered it but does that mean that this time is a compelling discount for Zomedica?
investorplace.com - March 12, 2021

Should You Buy Zomedica Stock in March? | The Motley Fool

It could be a good growth pick, but it probably won't repeat its recent blastoff.
www.fool.com - March 12, 2021

The Math Doesn't Work: Zomedica Stock Has Further to Fall

The market suddenly is paying more attention to valuation. That's a problem for ZOM stock, which looks drastically overvalued from any angle.
investorplace.com - March 11, 2021

ZOM Stock Could Hold Steady, but It's Hardly a Buy at Today's Prices

While enthusiasm for ZOM stock remains high, the shaky bull case for this pet diagnostics play is a sign the best move is to steer clear.
investorplace.com - March 11, 2021

Here's Why $5 in ZOM Stock Is Looking Possible

There's plenty and growing reasons off and on the price chart for ZOM stock investors to be appreciatively upbeat about.
investorplace.com - March 10, 2021

Things Are About to Get Interesting for Zomedica

Zomedica's first product, Truforma, goes on sale at the end of the month. Will the nation's love of pets spur ZOM stock to profitability?
investorplace.com - March 09, 2021

Why Is Everyone Talking About Zomedica Stock? | The Motley Fool

This pet health company has made a few investors rich already, but more is still to come.
www.fool.com - March 06, 2021

Better Reddit Stock: Ocugen vs. Zomedica | The Motley Fool

Both are highfliers with intriguing potential.
www.fool.com - March 06, 2021

Zomedica Lacks Hard Numbers To Back Up Its Big Pets-n'-Pandemic Rally

ZOM stock has soared in 2021, but the company's fundamentals don't support the huge share price rise. Investors may be playing pump-and-dump.
investorplace.com - March 04, 2021

ZOM Stock: Zomedica Volatility Continues as Truforma Launch Nears

As Zomedica prepares to launch Truforma, its first commercial product, ZOM stock continues to experience volatility.
investorplace.com - March 02, 2021

Zomedica Is a Winner With Its Pet Lab Product and Cash Balance

Zomedica is a winner with its pet lab product and cash balance. ZOM stock is worth as much as $3.61 following its Truforma product launch.
investorplace.com - March 02, 2021

It May Be Too Early to Believe in Zomedica Stock

There are heavy expectations for ZOM stock, even though Zomedica still has no revenues and a measured plan to roll out its Truforma device.
investorplace.com - March 02, 2021

Zomedica Continues to Fly High With Its Recent Positive Developments

ZOM stock has been on a tear this year, and is nearing the buy zone with the impending release of its Truforma Platform
investorplace.com - March 02, 2021

ZOM Stock: Pros and Cons of Buying Zomedica Ahead of Key Product Launch

ZOM Stock has risen by more than 1,000% in the last three months as the launch of Truforma aproaches. However, investors may in for a shocker
investorplace.com - March 02, 2021

ZOM Stock: Why Zomedica Shares Are Zooming Higher Monday

Zomedica (ZOM) stock is gaining on Monday following the release of its results for the full year of 2020 and approaching product launch.
investorplace.com - March 01, 2021

Don’t Get Suckered into the Zomedica Trade

On a superficial level, it’s easy to get excited about ZOM stock. However, the harsh reality is that this is a classic pump and dump.
investorplace.com - March 01, 2021

All Bets are Off Whether Zomedica Stock Grows Into Its Valuation

This pet diagnostics play is many years from big success, so take your time before entering a position in ZOM stock.
investorplace.com - February 26, 2021

Zomedica Has Tails Wagging Over Its Product Release

Long-term, ZOM stock has plenty to look forward to, including the release of its diagnostics platform. But that doesn't mean it's infallible.
investorplace.com - February 24, 2021